Skip to main content
2023 AANS Annual Scientific Meeting Main banner
Back

Community Session

Tumor and Neuro Oncology Community

(NC5505) MIS Approaches to Meningioma

Monday, April 24, 2023
9:50am – 10:06am PST
Location: Los Angeles Convention Center, 411- Theater

    Moderator(s)

  • Gordon Li, MD

    Professor and Vice Chair, Faculty Affairs
    Stanford University Department of Neurosurgery
    Stanford, California, United States

  • Chetan Bettegowda, MD, PhD (he/him/his)

    Professor and Vice Chair
    Johns Hopkins
    Baltimore, Maryland, United States

    • Speaker(s)

  • Georgios A. Zenonos, MD (he/him/his)

    Assistant Professor of Neurosurgery, Co- Director, Center for Skull Base Surgery Co- Director, Neurosurgery Skull Base Fellowship Neurosurgical Co-Director, Pituitary Center of Excellence Director, Cranial Nerve Disorders Program Director of Clinical Operations, UPMC Presbyterian
    University of Pittsburgh Medical Center, Department of Neurosurgery
    PIttsburgh, Pennsylvania, United States

Disclosure(s):
Gordon Li, MD: Abbott: Stock Shareholder (excluding mutual funds) (Ongoing); Biogen: Stock Shareholder (excluding mutual funds) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Bristol Myers Squibb: Grant/Research Support (Terminated, February 6, 2023); gilead: Stock Shareholder (excluding mutual funds) (Ongoing); J&J/Synthes: Speaker/Honoraria (Terminated, February 6, 2023); Medtronic: Consultant (Ongoing); Merck: Stock Shareholder (excluding mutual funds) (Ongoing); Novocure: Grant/Research Support (Ongoing); Pfizer: Stock Shareholder (excluding mutual funds) (Ongoing); Photonic Medical: Advisor (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); stryker: Stock Shareholder (excluding mutual funds) (Ongoing)
Chetan Bettegowda, MD, PhD: Belay Diagnostics: Board Member/Officer/Trustee (Ongoing), Ownership Interest (Ongoing); Bionaut Labs: Consultant (Ongoing); Depuy-Synthes: Consultant (Ongoing); Galectin Therapeutics: Consultant (Ongoing); Haystack Oncology: Consultant (Ongoing); OrisDx: Board Member/Officer/Trustee (Ongoing), Ownership Interest (Ongoing); Privo Technology: Consultant (Ongoing)
Georgios A. Zenonos, MD: No financial relationships to disclose